International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Evaluation of Serum Adiponectin Concentrations Among Drug Abusers on Methadone Maintenance Treatment

Farzaneh Montazerifar 1 , 2 , 3 , * , Mansour Karajibani 2 , 3 , Kobra Lashkaripour 2 , 4 and Maryam Yousefi 4
Authors Information
1 Pregnancy Health Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
2 Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
3 Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran
4 Department of Psychiatry and Psychology, Baharan Psychatric Hospital, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: December 01, 2013, 2 (3); 117-2
  • Published Online: December 24, 2013
  • Article Type: Research Article
  • Received: August 4, 2013
  • Revised: October 7, 2013
  • Accepted: November 2, 2013
  • DOI: 10.5812/ijhrba.14021

To Cite: Montazerifar F, Karajibani M, Lashkaripour K, Yousefi M. Evaluation of Serum Adiponectin Concentrations Among Drug Abusers on Methadone Maintenance Treatment, Int J High Risk Behav Addict. 2013 ; 2(3):117-2. doi: 10.5812/ijhrba.14021.

Copyright © 2013, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Housova J, Wilczek H, Haluzik MM, Kremen J, Krizova J, Haluzik M. Adipocyte-derived hormones in heroin addicts: the influence of methadone maintenance treatment. Physiol Res. 2005; 54(1): 73-8[PubMed]
  • 2. Frischer M, Hickman M, Kraus L, Mariani F, Wiessing L. A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction. 2001; 96(10): 1465-76[DOI][PubMed]
  • 3. Ross LJ, Wilson M, Banks M, Rezannah F, Daglish M. Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment. Nutrition. 2012; 28(7-8): 738-43[DOI][PubMed]
  • 4. Alves D, Costa AF, Custódio D, Natário L, Ferro-Lebres V, Andrade F. Housing and employment situation, body mass index and dietary habits of heroin addicts in methadone maintenance treatment. Heroin Addict Relat Clin Probl. 2011; 13(1): 11-4
  • 5. Kheradmand A, Banazadeh N, Abedi H. Physical Effects of Methadone Maintenance Treatment from the Standpoint of Clients. Addict Health. 2010; 2(3-4): 66-73
  • 6. Havel PJ. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002; 13(1): 51-9[PubMed]
  • 7. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004; 53-51[PubMed]
  • 8. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003; 148(3): 293-300[PubMed]
  • 9. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004; 68(11): 975-81[PubMed]
  • 10. Imagawa A, Funahashi T, Nakamura T, Moriwaki M, Tanaka S, Nishizawa H, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care. 2002; 25(9): 1665-6[PubMed]
  • 11. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab. 2007; 92(2): 571-6[DOI][PubMed]
  • 12. Matsubara M, Yoshizawa T, Morioka T, Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. J Atheroscler Thromb. 2000; 7(1): 50-4[PubMed]
  • 13. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000; 102(11): 1296-301[PubMed]
  • 14. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER, et al. The association between adiponectin and diabetes in the Korean population. Metabolism. 2008; 57(6): 853-7[DOI][PubMed]
  • 15. Jalovaara K, Santaniemi M, Timonen M, Jokelainen J, Kesaniemi YA, Ukkola O, et al. Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism. 2008; 57(8): 1130-4[DOI][PubMed]
  • 16. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care. 2002; 25(6): 971-6[PubMed]
  • 17. Sanjari M, Khodashahi M, Gholamhoseinian A, Shokoohi M. Association of adiponectin and metabolic syndrome in women. J Res Med Sci. 2011; 16(12): 1532-40[PubMed]
  • 18. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002; 51(9): 2734-41[PubMed]
  • 19. Centers for Disease Control and Prevention . Credible health information 2009;
  • 20. Krause MV, Mahan LK, Escott-Stump S, Raymond JL. Krause's food & the nutrition care process. 2012;
  • 21. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86(5): 1930-5[PubMed]
  • 22. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003; 46(4): 459-69[DOI][PubMed]
  • 23. Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments. Diabetes. 2002; 51(4): 1005-15[PubMed]
  • 24. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002; 87(12): 5662-7[DOI][PubMed]
  • 25. Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes. 2003; 52(4): 942-7[PubMed]
  • 26. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1): 79-83[PubMed]
  • 27. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, et al. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003; 52(2): 239-43[PubMed]
  • 28. Alberti KG, Zimmet P, Shaw J, I. D. F. Epidemiology Task Force Consensus Group . The metabolic syndrome--a new worldwide definition. Lancet. 2005; 366(9491): 1059-62[DOI][PubMed]
  • 29. Expert Panel on Detection Evaluation, Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-97[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments